Vertex Pharmaceuticals Incorporated (VRTX) Q4 2015 Earnings Results

Vertex Pharmaceuticals Beats on EPS, Stock Up 0.33%

Vertex Pharmaceuticals reported a strong earnings per share, significantly beating expectations. The stock reacted positively, rising 0.33%. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.17	N/A	+209.68%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the earnings surprise. They emphasized their commitment to pipeline development but did not provide specific guidance.

We are pleased with our EPS performance this quarter.

Our focus remains on advancing our pipeline.

Vertex Pharmaceuticals Beats on EPS, Stock Up 0.33%

Key numbers

Management commentary

Vertex Pharmaceuticals Incorporated

More earnings this week

Vertex Pharmaceuticals Beats on EPS, Stock Up 0.33%

Key numbers

Management commentary